71
Views
10
CrossRef citations to date
0
Altmetric
Original

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma

, , , , , , , , , , , & show all
Pages 1290-1294 | Received 01 Aug 2005, Accepted 10 Oct 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nicolas Leupin, Jan C. Schuller, Max Solenthaler, Dominik Heim, Alicia Rovo, Kurt Beretta, Michael Gregor, Mario J. Bargetzi, Peter Brauchli, Andreas Himmelmann, Silvia Hanselmann & Reinhard Zenhäusern. (2010) Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02). Leukemia & Lymphoma 51:4, pages 613-619.
Read now

Articles from other publishers (9)

Ş M Bakanay & T Demirer. (2011) Novel agents and approaches for stem cell mobilization in normal donors and patients. Bone Marrow Transplantation 47:9, pages 1154-1163.
Crossref
Partow KebriaeiHelen HulsBipulendu JenaMark MunsellRineka JacksonDean A. LeePerry B. HackettGabriela RondonElizabeth ShpallRichard E. ChamplinLaurence J.N. Cooper. (2012) Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies. Human Gene Therapy 23:5, pages 444-450.
Crossref
Ashanka Beligaswatte, Ian Lewis & Luen Bik To. 2012. Twenty Years of G-CSF. Twenty Years of G-CSF 249 275 .
Partow Kebriaei, Timothy Madden, Reza Kazerooni, Xuemei Wang, Peter F. Thall, Celina Ledesma, Yago Nieto, Elizabeth J. Shpall, Chitra Hosing, Muzaffar Qazilbash, Uday Popat, Issa Khouri, Richard E. Champlin, Roy B. Jones & Borje S. Andersson. (2011) Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies. Biology of Blood and Marrow Transplantation 17:3, pages 412-420.
Crossref
Celso Arrais Rodrigues, Poliana Alves Patah, Yana A. S. Novis, Chitra Hosing & Marcos de Lima. (2010) The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed Settings. Current Hematologic Malignancy Reports 6:1, pages 47-57.
Crossref
Tomas Papajik, Zuzana Pikalova, Ludek Raida, Ivana Skoumalova, Jana Vondrakova, Edgar Faber, Vit Prochazka, Zuzana Kubova, Ladislava Kucerova, Tomas Pavlik, Ladislav Dusek & Karel Indrak. (2009) RITUXIMAB DOES NOT ADVERSELY AFFECT THE STEM CELL MOBILIZATION AND ENGRAFTMENT AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN FIRST COMPLETE OR PARTIAL REMISSION. Biomedical Papers 153:3, pages 211-214.
Crossref
E Copelan, B Pohlman, L Rybicki, M Kalaycio, R Sobecks, S Andresen, R Dean, A Koo, J Chan, J Sweetenham & B Bolwell. (2008) A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation 43:2, pages 101-105.
Crossref
Hani Mawardi, Corey Cutler & Nathaniel Treister. (2009) Medical management update: Non-Hodgkin lymphoma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 107:1, pages e19-e33.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.